Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma.

BACKGROUND & AIMS: Transarterial chemoembolization (TACE) is an important palliative treatment for unresectable hepatocellular carcinoma (HCC), but TACE-induced ischemic injury can upregulate angiogenic factors and is associated with poor prognosis. The aim of this study was to evaluate the safety and efficacy of concurrent conventional TACE and sorafenib in patients with unresectable HCC. METHODS: The primary objectives of this prospective, single-arm, phase II study were to evaluate safety and time to progression (TTP). Sorafenib was given 3 days after TACE and was administered for up to 24 weeks. Repeated TACE was performed on demand. Tumor response was assessed every 8 weeks. RESULTS: Fifty patients were treated and followed from July 2009 to May 2011. All patients were in Barcelona Clinic Liver Cancer (BCLC) stage B (82%) or C (18%). The median time of follow-up was 14.9 months and a median of 1 TACE session was given (range, 1-4). The median dose intensity of sorafenib was 68.7% (range, 37.3-100) of 800 mg daily. The most common reasons for dose reduction were hand-foot syndrome and thrombocytopenia. Thirty patients completed the study and 17 patients discontinued sorafenib due to disease progression. The overall median TTP was 7.1 months (95% confidence interval (CI), 4.8-7.5 months): 7.3 months in BCLC stage B; 5.0 months in BCLC stage C. The 6-month progression-free survival rate was 52% (95% CI, 37.3-66.1). CONCLUSIONS: Concurrent treatment of unresectable HCC with conventional TACE and sorafenib demonstrates a manageable safety profile and a possibility of promising efficacy.

Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma.

BACKGROUND AND AIM: Patients with hepatocellular carcinoma (HCC) that is refractory to repeated transarterial chemoembolization (TACE) are considered for systemic therapy, but TACE refractoriness is not well defined. The aim of this study was to determine the characteristics of patients whose HCC is refractory to repetitive TACE. METHODS: We evaluated 264 patients with intermediate-stage HCC who underwent TACE between January 2006 and September 2009. We designated the development of vascular invasion or extrahepatic spread during follow up as "stage progression" (SP), and hypothesized that SP might be the surrogate end-point for TACE refractoriness. RESULTS: The median follow up was 18.2 months, and median number of TACE was 3.0 (range, 1-13). Median time-to-progression was 5.5 months (95% confidence interval, 4.8-6.2), and median overall survival was 25.3 months (95% confidence interval, 21.6-29.0). We classified the patients according to disease course as: no progressive disease (PD(-); n = 33); PD without SP (PD(+)SP(-); n = 113); PD followed by SP (PD→SP; n = 47); and simultaneous PD and SP (PD&SP; n = 64). PD(-) and PD(+)SP(-) groups showed no difference in overall survival, PD→SP group had worse overall survival than PD(-) and PD(+)SP(-) groups, and PD&SP group had the worst overall survival. The significant prognostic factors for SP-free survival were development of PD and need for three sessions of TACE during the first 6 months. CONCLUSIONS: SP-free survival can be regarded as an end-point for TACE refractoriness. Development of progression or need for three sessions of TACE within the first 6 months could be predictive of TACE refractoriness.

Hepatocellular carcinoma: prediction of blood supply from an intercostal artery with multidetector row computed tomography.

PURPOSE: To evaluate the ability of multidetector row computed tomography (CT) to detect blood supply from the intercostal artery in patients with hepatocellular carcinoma (HCC). MATERIALS AND METHODS: Between January 2003 and December 2007, angiography of the intercostal artery was performed in 93 patients (76 men and 17 women, mean age 58 years) with HCC who had also undergone multidetector row CT. CT scans and digital subtraction angiograms of these patients were retrospectively reviewed by two investigators in consensus to evaluate tumor feeding vessels. Multiple logistic regression analysis was used to identify factors that predict the presence of an HCC blood supply from an intercostal artery. RESULTS: Tumor staining fed by an intercostal artery was noted in 65 patients (70%; 112 tumor feeding vessels) by intercostal angiography. Readers interpreted that tumor feeding vessels were evident by CT in 35 (54%) of these 65 patients with tumor staining supplied by an intercostal artery by angiography. Multiple logistic regression analysis showed that a visible tumor feeding vessel by CT (P = .003) and hepatic artery attenuation by angiography (P = .014) were significantly related to the presence of a blood supply from an intercostal artery. CONCLUSIONS: Visualization of a tumor feeding vessel from the intercostal artery by multidetector row CT is an important sign of parasitic supply to an HCC.

Transarterial chemoembolization of a colic branch of the superior mesenteric artery in patients with unresectable hepatocellular carcinoma.

PURPOSE: To evaluate the technical feasibility, safety, and imaging response of transarterial chemoembolization performed through a colic branch of the superior mesenteric artery (SMA) in patients with hepatocellular carcinoma (HCC). MATERIALS AND METHODS: Between July 2000 and June 2009, we observed tumor staining supplied by a colic branch of the SMA in 61 of 5,095 patients (1.2%) with HCC. Computed tomography (CT) scans and digital subtraction angiograms of these patients were retrospectively reviewed by two investigators in consensus to evaluate the tumor location, the technical success of chemoembolization, complications, and imaging response on a follow-up CT scan according to European Association for the Study of the Liver criteria. RESULTS: Tumors supplied by a colic branch of the SMA were located in segment VI (n = 58) or were extrahepatic metastases caused by peritoneal seeding (n = 3). Vessels supplying the tumor arose from the right colic artery (n = 23), middle colic artery (n = 22), or ileocolic artery (n = 26). Selective chemoembolization via a colic branch of the SMA was performed in 24 patients (39%). No patient developed symptoms related to colon ischemia. Complete response or partial response of the tumor fed by a colic branch of the SMA as depicted on follow-up CT was achieved in eight patients (33%). CONCLUSIONS: Chemoembolization via a colic branch of the SMA can be safely performed if the microcatheter can be advanced beyond the antimesenteric border of the colon.

Intercostal artery supplying hepatocellular carcinoma: demonstration of a tumor feeder by C-arm CT and multidetector row CT.

This study was designed to describe tumor feeders from the intercostal artery supplying hepatocellular carcinoma (HCC) on C-arm CT and multidetector row CT. From March 2008 to May 2009, C-arm CT of the intercostal artery was prospectively performed in 24 HCC patients. Two interventional radiologists, who performed C-arm CT, evaluated tumor feeders on C-arm CT and multidetector row CT scans by consensus. In total, 35 intercostal arteries were examined by C-arm CT. All tumor feeders except one showed a sharp upward turn at or near the costochondral junction. On axial C-arm CT images, all tumor feeders were observed as an enhancing dot in the upper intercostal space along the diaphragm. On multidetector CT scans, 17 tumor feeders were observed and 18 were not. Tumor feeders from the intercostal artery are observed as an enhancing dot along the diaphragm on C-arm CT and can be seen on multidetector row CT in approximately half of patients.

Chemoembolization of the left inferior phrenic artery in patients with hepatocellular carcinoma: 9-year single-center experience.

OBJECTIVE: The purpose of this study was to evaluate retrospectively the radiologic findings and imaging response of hepatocellular carcinoma supplied by the left inferior phrenic artery. MATERIALS AND METHODS: From January 2000 through December 2008, chemoembolization of the left inferior phrenic artery was performed on 152 patients (123 men, 29 women; mean age, 55.8 years) with hepatocellular carcinoma. The CT scans and digital subtraction angiograms of these patients were retrospectively reviewed in consensus by two investigators, who evaluated tumor location, tumor-feeding vessels, origin of the left inferior phrenic artery, technical success of chemoembolization, complications, and tumor response. Tumor response was assessed on the basis of the criteria of the European Association for the Study of the Liver. RESULTS: Tumors supplied by the left inferior phrenic artery were located in Couinaud segment 2/3 (n = 100), segment 4 (n = 45), and other segments (n = 7). The most common tumor-feeding vessel was the anteromedial limb of the left inferior phrenic artery (n = 82) followed by the lateral limb (n = 40) and the anterior limb (n = 30). Selective chemoembolization via the left inferior phrenic artery was achieved in 58 of the patients (38%). Complete or partial response as detected on first follow-up CT images (mean follow-up time, 2.5 months) was achieved by 30 patients. In 33 patients in whom the tumor was supplied exclusively by the left inferior phrenic artery, the tumor response was more favorable in patients who underwent selective than in those who underwent nonselective chemoembolization via the left inferior phrenic artery (p = 0.028). CONCLUSION: Selective chemoembolization via the left inferior phrenic artery is possible and results in good response of tumors supplied exclusively by the left inferior phrenic artery.

Left inferior phrenic artery feeding hepatocellular carcinoma: angiographic anatomy using C-arm CT.

OBJECTIVE: The left inferior phrenic artery (LIPA) is one of the common extrahepatic collateral arteries that supply hepatocellular carcinomas (HCCs). The purpose of this study is to describe the anatomy of the LIPA that supplies HCCs using C-arm CT in 23 patients. CONCLUSION: The anteromedial limb of the ascending branch was present in 14 patients and accessory gastric branches were noted in 11 patients. The use of angiography and C-arm CT of the LIPA showed 26 tumor feeders in 23 patients. The feeders were seen in the anteromedial limb (n = 12), lateral limb (n = 9), anterior limb (n = 3), and descending branch (n = 2). The anteromedial limb of the ascending branch is a common tumor feeder of the LIPA and can supply HCCs located in the right liver dome. Gastric staining is also frequently depicted on LIPA angiography and should not be confused with tumor staining.

An anthropomorphic phantom study of computer-aided detection performance for polyp detection on CT colonography: a comparison of commercially and academically available systems.

OBJECTIVE: The objective of our study was to compare the diagnostic performances of two commercial computer-aided detection (CAD) systems and a CAD system developed in our laboratory, which we refer to as an "academic CAD system," for polyp detection on CT colonography (CTC) and to assess the detection characteristics of the CAD systems. MATERIALS AND METHODS: One hundred three polyps (48 polyps < 6 mm and 55 polyps > or = 6 mm; 45 sessile, 33 flat, and 25 pedunculated polyps) were created. Each CTC data set was analyzed using two commercial CAD systems (Computer Assisted Reader [CAR] and Polyp Enhanced View [PEV]) and one Hessian matrix-based academic CAD system. Per-polyp sensitivities according to polyp size and shape were compared among the three CAD systems. The average number and causes of false-positives (FPs) were analyzed and compared. RESULTS: Per-polyp sensitivity for all polyps was significantly better for the academic CAD system (83.5%) than for both commercial CAD systems (64.1%) (p < 0.01). However, the difference in per-polyp sensitivity for polyps > or = 6 mm was not significant (p > 0.017). According to morphology, per-polyp sensitivities as determined with the CAR, PEV, and academic CAD systems for flat, sessile, and pedunculated polyps were 51.5%, 57.6%, and 81.8%; 60.0%, 62.2%, and 84.4%; 88.0%, 76.0%, and 84.0%, respectively. The average number of FPs was not significantly different (p > 0.05); however, the distribution of the causes of FPs for the three systems was significantly different (p < 0.001). CONCLUSION: For polyps > or = 6 mm, the three CAD systems showed comparable per-polyp sensitivities. Although the number of FPs was not significantly different, the distribution of the causes of FPs for each of the CAD systems was significantly different.

Transcatheter arterial chemoembolization for hepatocellular carcinoma: prospective assessment of the right inferior phrenic artery with C-arm CT.

PURPOSE: To assess the usefulness of C-arm computed tomography (CT) of the right inferior phrenic artery (RIPA) in transcatheter arterial chemoembolization of patients with hepatocellular carcinoma (HCC). MATERIALS AND METHODS: From December 2007 to April 2008, C-arm CT of the RIPA was prospectively performed in 32 patients with HCC. Two interventional radiologists who performed C-arm CT assessed the additional information provided with C-arm CT as grade 1 (no additional information), grade 2 (added information without an effect on the treatment plan), or grade 3 (added information with an effect on the treatment plan). Tumor feeders and feeders of a systemic-to-pulmonary shunt were recorded. RESULTS: The information provided by C-arm CT was classified as grade 1 for nine of the 32 patients (28%), grade 2 for 20 patients (63%), and grade 3 for three patients (9%). The most common additional information from C-arm CT scans of the RIPA was the differentiation between the tumor and the systemic-to-pulmonary shunt. A systemic-to-pulmonary shunt from the RIPA was observed in 22 patients (69%), and the most common feeder of a systemic-to-pulmonary shunt was the azygoesophageal branch. CONCLUSIONS: C-arm CT of the RIPA provides additional imaging information for the differentiation of a tumor from a nontumorous condition during chemoembolization for HCC with a suspected blood supply from an RIPA.

Hepatocellular carcinoma: detection of blood supply from the right inferior phrenic artery by the use of multi-detector row CT.

PURPOSE: To evaluate retrospectively the ability of multi-detector row computed tomography (CT) to detect blood supply from the right inferior phrenic artery (RIPA) in patients with hepatocellular carcinoma (HCC). MATERIALS AND METHODS: Between July 2006 and June 2007, angiography of the RIPA was performed in 178 patients (151 men, 27 women; mean age, 59 years) with HCC who also had undergone multi-detector row CT. CT scans and digital subtraction angiograms of these patients were retrospectively reviewed by consensus by two investigators to evaluate tumor feeder vessels. RESULTS: Tumor staining fed by the RIPA was noted on angiography in 113 patients (63%). Readers interpreted that the tumor feeder vessels were evident on CT images in 63 of these 113 patients (56%). Young age (odds ratio [OR], 0.934; P < .0001), exophytic growth pattern (OR, 2.702; P = .009), and presence of a visible feeder vessel on CT (OR, 6.933; P < .0001) were significant factors for predicting parasitic blood supply from the RIPA. In a subgroup of tumors smaller than 5 cm, multivariate analysis revealed that young age (OR, 0.94; P = .03) and repeated chemoembolization sessions (OR, 8.65; P = .01) were significant factors. CONCLUSIONS: Visualization of a tumor feeding vessel from the RIPA on multi-detector row CT could be a clue of a parasitic supply of a large tumor. In patients who have received repeated chemoembolization, small tumors in the dorsal hepatic area can be supplied by the RIPA.

Screening CT colonography in an asymptomatic average-risk Asian population: a 2-year experience in a single institution.

OBJECTIVE: The purpose of our study was to report the results of screening CT colonography (CTC) in an asymptomatic average-risk Asian population. MATERIALS AND METHODS: In 2005 and 2006, 1,015 Korean adults (609 men and 406 women; mean age, 51 years) underwent screening CTC using a 16-MDCT scanner and an automated CO2 delivery system. During the study period, the protocols were changed to use less vigorous purgation and lower radiation doses; fecal tagging (n = 890) and primary 3D interpretation (n = 966) were generally used. CTC results were categorized as C0, inadequate; C1, no significant polyp; C2, one or two 6- to 9-mm polyps; C3, polyps > or = 10 mm or > or = three 6- to 9-mm polyps; and C4, mass. Patients with positive CTC results were referred to gastroenterologists for follow-up or management planning. RESULTS: Categories C0-C4 were assigned to 21 (2.1%), 916 (90.2%), 54 (5.3%), 23 (2.3%), and one (0.1%) patients, respectively. Fifty-four patients with C4 (n = 1), C3 (n = 20), or C2 (n = 33) underwent subsequent optical colonoscopy: complete (n = 53) and incomplete (n = 1). Per-patient positive predictive values (PPVs) for categories C3-C4 and C2-C4 were 90% (18/20) and 74% (39/53), respectively. Per-polyp PPVs at 10- and 6-mm thresholds were 92% (22/24) and 69% (45/65), respectively. The diagnostic yield for advanced neoplasm was 1.5% (15/1,015). CONCLUSION: Our results seem comparable to Western experiences, showing that a successful screening CTC program can be reproduced in an Asian population.